Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial

Chinese Medical Journal
Kwang-Min KimKyung-Soo Kim

Abstract

Fatigue is a common symptom both in diseases status and in healthy subjects. Various supplements and nutraceuticals for relieving of fatigue have been used. However, there are a few studies to evaluate the efficacy and the safety of the drug for fatigue alleviation, we conducted using URSA Complex to evaluate the efficacy on physical fatigue via score changes in the checklist individual strength (CIS). The study was designed as a multicenter, randomized, double-blind, placebo-controlled trial, with subjects randomized to one of the two arms, receiving either placebo or URSA Complex administered as identical capsules. The primary efficacy endpoints of this clinical trials are the ratio of improving CIS scores < 76 points in patients at the end (4 weeks). Secondary efficacy variables are as follows one is an improvement of fatigue and the other is an improvement of the liver enzyme. The fatigue recovery rate in who had improved CIS scores of < 76 points were 70.0%, 50.9% in the therapy group and placebo group, respectively (P = 0.019). The fatigue recovery rate in CIS score was higher in URSA Complex therapy group than placebo group. The difference between therapy group and placebo group was statistically significant at 4 weeks l...Continue Reading

References

Mar 1, 1990·Comprehensive Psychiatry·G E Berrios
Dec 1, 1996·Current Opinion in Neurology·L B Krupp, D A Pollina
Feb 1, 1997·Postgraduate Medical Journal·S Saksena, R K Tandon
Apr 19, 2000·Occupational and Environmental Medicine·A J BeurskensG M Swaen
Aug 10, 2000·Canadian Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquée·H Oueslati, P Gardiner
Mar 4, 2003·Journal of Lipid Research·Laura A WoollettJames E Heubi
May 28, 2003·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Yoshihisa YatabeNaoyuki Ochiai
Dec 9, 2004·BMJ : British Medical Journal·Maja StulemeijerGijs Bleijenberg
Aug 9, 2005·Free Radical Biology & Medicine·Gwen KennedyJill J F Belch
Jun 19, 2007·Gut·Masao OmataUNKNOWN Japanese C-Viral Hepatitis Network
Nov 24, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Tadashi Ikegami, Yasushi Matsuzaki
May 7, 2009·Journal of Lipid Research·Joana D AmaralCecília M P Rodrigues
Jun 13, 2009·World Journal of Gastroenterology : WJG·Shuichi SatoYoshikazu Kinoshita
Jul 16, 2010·Journal of Psychosomatic Research·Azmeh ShahidColin M Shapiro
Feb 3, 2011·Rheumatology·Katrine B NorheimRoald Omdal
Oct 4, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Kang-Kon LeeMoon-Jong Kim
Nov 1, 2013·BMC Gastroenterology·Halka BuryovaRadislav Sedlacek
Nov 22, 2013·Journal of Pharmacological Sciences·Osamu NakagawasaiKoichi Tan-No
Jan 8, 2015·Journal of Exercise Nutrition & Biochemistry·Sung-Keun ChoiSeung-Wook Choi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02418130

Software Mentioned

SAS
[UNK] System

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.